03 / 053360 A3 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||. 2. WO. ( 12 ) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY ( PCT ) . ( 19 ) World Inteﬂectual Property Organization Internationa1 Bureau. ( 43 ) International Publication Date. 3 July 2003 ( 03.07.2003 ) . . PCT. C1. r : ' ' ' - ' n r I I L w : ‘i T r - n ' ‘ c . J h. ( 10 ) International Publication Number. WO 2003 / 053360 A3. . A61K 31 / 70 , . ( 51 ) Internati0nal Patent Classiﬁcation7 : C07H 19 / 06. ( 21 ) International Application Number : PCT / US2002 / 040853. ( 22 ) International Fi ] ing Date : 19 December 2002 ( 19.12.2002 ) . ( 25 ) Filing Language : English. ( 26 ) Pub ] ication Language : Eng1ish ( 30 ) Priority Data : . 60 / 345 , 130 20 December 2001 ( 20.12.2001 ) US. ( 71 ) Applicants ( f0r all designated States except US ) : PHARMASSETT LTD. [ BB / BB ] ; The Financial SerVices Center , Suite 111 , Bishops Court Hill , St. Michael , Barbados , West Indies ( BB ) . BETH ISRAEL DEACONESS MEDICAL CENTER [ JP / US ] ; 330 Brookhne AVe. , Boston , MA 02215 ( US ) . EMORY UNIVERSITY [ US / US ] ; 1380 South OXford Road , Atlanta , GA 30322 ( US ) . ( 72 ) Inventors ; and. ( 75 ) Inventors / Applicants ( f0r US 0nly ) : SCHINAZI , Raymond , F. [ US / US ] ; 1524 Regency Wa1k DriVe , Decatur , GA 30033 ( US ) . SHI , JunXing [ CN / US ] ; 3345 McClure Woods DriVe , Du1uth , GA 30096 ( US ) . FINGEROTH , Joyce , D. [ US / US ] ; 64 Canterbury DriVe , Sudbury , MA 01776 ( US ) . GUSTAFSON , Erik [ US / U S ] ; 140 Plymouth DriVe #C , Norwood , MA 02062 ( US ) . ( 74 ) Agent : KNOWLES , Sherry , M. ; King & Spalding , 191 Peachtree Street , At1anta , GA 30303 - 1763 ( US ) . ( 81 ) Designated States ( nati0nal ) : AE , AG , AL , AM , AT , AU , AZ , BA , BB , BG , BR , BY , BZ , CA , CH , CN , CO , CR , CU , CZ , DE , DK , DM , DZ , EC , EE , ES , FI , GB , GD , GE , GH , GM , HR , HU , ID , IL , IN , IS , JP , KE , KG , KP , KR , KZ , LC , LK , LR , LS , LT , LU , LV , MA , MD , MG , MK , MN , MW , MX , MZ , NO , NZ , OM , PH , PL , PT , RO , RU , SC , SD , SE , SG , SK , SL , TJ , TM , TN , TR , TT , TZ , UA , UG , US , UZ , VC , VN , YU , ZA , ZM , ZW. ( 84 ) Designated States ( regi0nal ) : ARIPO patent ( GH , GM , KE , LS , MW , MZ , SD , SL , SZ , TZ , UG , ZM , ZW ) , Eurasian patent ( AM , AZ , BY , KG , KZ , NID , RU , TJ , TM ) , European patent ( AT , BE , BG , CH , CY , CZ , DE , DK , EE , ES , FI , FR , GB , GR , IE , IT , LU , MC , NL , PT , SE , SI , SK , TR ) , OAPI patent ( BF , BJ , CF , CG , CI , CM , GA , GN , GQ , GW , NIL , MR , NE , SN , TD , TG ) . Published : . — with internati0nal search rep0rt. — bef0re the expirati0n 0f the time limit f0r amending the ClaimS and t0 be republished in the event 0f reCeipt 0f amendments. ( 88 ) Date of publication of the international search report : 7 July 2005. F0r tw0—letter CodeS and 0ther abbreviati0ns , refer t0 the "Guidance N0tes 0n C0des and Abbreviations ” appearing at the beginning 0f each regnlar issne 0f the PCT Gazette. . ( 54 ) Title : TREATMENT OF EBV AND KHSV INFECTION AND ASSOCIATED ABNORMAL CELLULAR PROLIFERA—. TION. ( 57 ) Abstract : A method and composition for the treatment , preVention and / or prophylaXis of a host , and in particu1ar , a human , infected with Epstein—Barr Virus ( EBV ) , is proVided that includes administering an effectiVe amount of a 5—substituted uracil nuc1e— oside or its pharmaCeuticaHy acceptable sa1t or prodrug , optionally in a pharmaceutically acceptab1e di1uent or eXcipient. . INTERNATIONAL SEARCH REPORT International app1ication No. . . PCT / US02 / 40853 A. CLASSIFICATION OF SUBJECT MATTER IPC ( 7 ) : A61K 31 / 70 ; C07H 19 / 06 US CL : 514 / 50 ; 536 / 28.53. According to International Patent Classiﬁcation ( IPQ or to both national cIassification and IPC B. FIELDS SEARCHED. Minimum documentation searched ( c1assiﬁcation system followed by classification symbols ) U. S. : 514 / 50 ; 536 / 28.53. . . . Documentation searched other than minimum documentation to the extent that such documents are inc1uded in the ﬁelds searched. . Electronic data base consulted during the international search ( name of data base and , where practicab1e , search terms used ) Please See Continuation Sheet. . C. DOCUMENTS CONSIDERED TO BE RELEVANT. . . Category * Citation of document , with indication , where appropriate , of the re1evant passages Relevant to claim No. Y US 4 , 681 , 933 A ( CHU et aI ) 21 July 1987 ( 21.07.1987 ) see entire document. 1 - 81 Y US 4 , 841 , 039 A ( CHU et a1. ) 20 lune 1989 ( 20.06.1989 ) see entire document. 1—81 Y US 4 , 542 , 210 ( SAKATA ct al ) 17 September 1985 ( 17.09.1985 ) , columns 1—4. 1—81 Y US 4 , 957 , 924 ( BEAUCHAMP ) 18 September 1990 ( 18.09.1990 ) , see entire document. 1—81 X US 5 , 356 , 882 ( WALKER et al ) 18 October 1994 ( 18.10.1994 ) , columns 2 - 4. 1 - 81 X US 5 , 565 , 438 ( CHU et a1 ) 15 October 1996 ( 15.10.1996 ) , see entire document. 1—81 X US 5 , 587 , 362 ( CHU eta1 ) 24 December 1996 ( 24.12.1996 ) , see entire document. 1—81 X US 6 , 022 , 876 ( CHU et a1 ) 8 February 2000 ( 08.02.2000 ) , see entire document. 1—8l X WATANABE et al. , Synthesis of Antiviral Nucleosides : 5 - Alkeny1~1— ( 2~deoxy - 2 - fluoro - B - 1~81. D—arabinofuranosy1 ) uraci1s. J. Med. Chem. , 1984 Vol. 27 , pp. 91—94. . . . . . . . . . . . . Further documents are listed in the continuation of Box C. See patent family annex. * Special categories of cited documents : “T ” later document published after the internationa1 ﬁling date or priority date and not in conﬂict with the app1ication but cited to understand the “A ” document deﬁning the general state of the art which is not considered to be principle or theory underlying the invention. of particular relevance “X " document of particular relevance ; the claimed invention cannot be. “E ” earlier application or patent published on or aher the international ﬁling date considered nove1 or cannot be considered to involve an inventive step when the document is taken alone “L ” document which may throw doubts on priority claim ( s ) or which is cited to establish the publication date of another citation or other special reason ( as “Y " document of particular relevance ; the c ] aimed invention cannot be specified ) considered to involve an inventive step when the document is combined with one or more other such documents , such combination “O “ document referring to an oral disc1osure. use , exhibition or other means beiug obvious to a person skilled in the art “P" document published prior to the international ﬁling date but later than the “6 ' ; document member of the same patent famﬂy. priority date claimed. . Date of the actuaI completion of the international search Date of f§mﬁif the ﬁﬁﬁﬁﬁﬁﬁ search report 01 CCtober 2003 ( 01.10.2003 ) . Name and mailing address of the ISAJUS Authorized 0fficerCﬂ WWWW. Mail Stop PCT , Atm : ISAfUS Howard V Owens. . Commissioner for Patents. it ' Ig : £ai3z3 : - ia1 , 4i5t?rginta 22313 - 1450 TelePhtme N0 - 703 - 308 - 1235. . FacsimiIe No. ( 703 ) 305—3230 Form PCT / ISA / 210 ( second sheet ) ( July 1998 ) . . . . . . INTERNATION AL SEARCH REPORT. . PCT / US02 / 40853. . . C. ( Continuation ) DOCUMENTS CONSIDERED TO BE RELEVANT. . Category * Citation of document , with indication , where appropriate , of the relevant passages. m. Relcvant to c1aim No. . X W YAO et al. , 1nhibition of Epstein—Barr Virus Replication by a NOvel L - Nucleoside , 2 ' Fluoro - 5 - Inethyl - B - L - arabinoﬁnanosyluracil. Biochemical Pharmacology , VoI. 5l , 1996 , pp. 94I - 947. X 33 PAGAN 0. J. Epstein - Barr Virus : Therapy of Active and Latent Infection. Antiviral Chemotherapy , 1995. X RAHZlM et al. Synthesis and Anti - Herpes Virus Activity of 2 ' —Deoxy - 4 ' - Thiopyrimidine Nucleosides. J. Med. Chem. , Vol. 39 , I996 , pp. 789 - 95. . . . I - 8l. l - 81. 1 - 81. . Form PCT / ISA / 2l0 ( second sheet ) ( JuIy l998 ) . . . . PCT / US02 / 40853 INTERNATIONAL SEARCH REPORT. . . . Continuation of B. FIELDS SEARCHED Item 3 : CAPLUS. BIOSIS. WEST. . Form PCT / ISA / 210 ( second sheet ) ( Iuly 1998 )